Skip to content
  • Home
Menu
  • Home
Login

Therapeutic Goods Administration (TGA)

  1. Home>
  2. Arts>
  3. Therapeutic Goods Administration (TGA)>
  4. Page 8

Joint enforcement activity with TGA and partner authorities sees Victoria Police arrest eight individuals

  • Post author:
  • Post published:17/11/2024
  • Post category:

The Victorian illicit vape and tobacco supply chain has been significantly weakened, with Victoria Police charging eight people with Commonwealth offences for their part in directing and assisting an organised…

Continue ReadingJoint enforcement activity with TGA and partner authorities sees Victoria Police arrest eight individuals

Medical devices affected by the 3G network shutdown

  • Post author:
  • Post published:17/11/2024
  • Post category:

The 3G network shutdown may impact certain medical devices and personal alarms. Consumers, healthcare providers, manufacturers, and suppliers should take the necessary precautions to prevent any disruption in essential medical…

Continue ReadingMedical devices affected by the 3G network shutdown

Addressing misinformation about excessive DNA in the mRNA vaccines

  • Post author:
  • Post published:17/11/2024
  • Post category:

The Therapeutic Goods Administration (TGA) is aware of misinformation in recent media and online reports that claim the COVID-19 mRNA vaccines are contaminated with excessive levels of DNA. This is…

Continue ReadingAddressing misinformation about excessive DNA in the mRNA vaccines

Nitrosamine impurities acceptable intakes update – October 2024

  • Post author:
  • Post published:17/11/2024
  • Post category:

Nitrosamines in medicinesWe have published updated acceptable intake (AI) information for nitrosamine impurities in medicines consistent with recent EMA updated information. The changes include additional clarification for sponsors and manufacturers…

Continue ReadingNitrosamine impurities acceptable intakes update – October 2024

TGA’s decision to not register lecanemab (LEQEMBI)

  • Post author:
  • Post published:17/11/2024
  • Post category:

The Therapeutic Goods Administration (TGA) has made the decision not to register lecanemab (LEQEMBI) for the treatment of patients with Mild Cognitive Impairment (MCI) due to Alzheimer's disease and Mild…

Continue ReadingTGA’s decision to not register lecanemab (LEQEMBI)
  • Go to the previous page
  • 1
  • …
  • 5
  • 6
  • 7
  • 8
  • 9
  • Go to the next page
  • Become an employer
    • Post Your Job
    • Business Account
    • Resource Center
    • Community
Copyright - OceanWP Theme by OceanWP

Form successfully submitted. One of our GRI rep will contact you shortly

Thanking You!

Click here

Enter your Email

Enter your registered username/email id.

Verify OTP

An OTP has been sent to your registered email address.

Enter your Email

Enter your email id below to signup.

Verify Email

Enter the 4-digit OTP shared on your email

Edit

Tell us more about yourself

Enter your name and organization

Select your work area

This will helps us to provide you with better personalisation and experience

Select your country

This will helps us to provide you with better personalisation and experience

All set.

Welcome, ! Your GRI account has been successfully set up.
Visit Dashboard
Individual Plan
  • Designed for Growing Compliance Teams
$125 / month OR $1250 / year
Features
  • • Coverage for 20 jurisdictions
  • • Monitoring from 500+ regulatory authorities
  • • AI compliance summaries
  • • RaDa.ai : Single-Role
Best for: Researchers, Legal professionals, Academics
Subscribe Now
Enterprise Plan
  • Perfect for Global Enterprises
Contact for Pricing
Features
  • • Custom jurisdictional coverage
  • • Custom monitoring of regulatory authorities
  • • RaDa.ai : Customizable multi-role
  • • Custom reporting and dashboard capabilities
  • • API access for seamless integration
Best for: Law Firms, Corporations, Government Bodies
Contact Sales